Xtandi gets EU approval
June 26, 2013Sales and Marketing Astellas, FDA, Xtandi
Astellas Pharma’s Xtandi has been approved in the European Union for the treatment of adult men with advanced prostate cancer, …
NICE finalises tamoxifen guidance
June 26, 2013Sales and Marketing Evista, NICE, lilly, tamoxifen
Women at risk of breast cancer can now be offered a daily pill on the NHS to stop the disease …
Allergan announces new president
June 26, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, ingram
Allergan has hired Douglas Ingram to be its president and lead the company’s global commercial operations. In this newly established …
Sanofi chief executive to lead EFPIA
June 26, 2013Research and Development, Sales and Marketing EFPIA, GSK, Sanofi, Viehbacher, Witty
Chief executive of Sanofi Christopher Viehbacher has been elected to serve as president of the European Federation of Pharmaceutical Industries …
Ranbaxy facing another facility problem?
June 26, 2013Manufacturing and Production FDA, Ranbaxy
Another facility operated by Ranbaxy Laboratories in India is reported to have failed an inspection by the FDA, potentially adding …
NICE completes Forxiga U-turn
June 26, 2013Sales and Marketing BMS, Forxiga, NICE
Bristol-Myers Squibb and AstraZeneca are celebrating after NICE reversed its decision from earlier this year and is now recommending their …
Merck Serono censured over calls
June 25, 2013Medical Communications, Sales and Marketing ABPI, Erbitux, Merck Serono, PMCPA
A Merck Serono medical representative has been accused of ‘harassing’ an anonymous health professional by requesting a meeting every month …
Lilly diabetes drug beats rivals
June 25, 2013Sales and Marketing BMS, diabetes, dulaglutide, lilly
New clinical trial results have shown Lilly’s investigational type 2 diabetes drug has beaten its three nearest rivals in reducing …
Roger Graham appointed president of Mylan Specialty
June 25, 2013Manufacturing and Production, Research and Development, Sales and Marketing Mylan, graham, specialty
Mylan has hired previous J&J vice president Roger Graham to be president of its specialty business. Graham will report to …
US gains exemption from EU requirements on API imports
June 25, 2013Manufacturing and Production API, FDA, hamburg
The US has joined the short list of countries from which suppliers can ship active pharmaceutical ingredients into the EU …
GSK mulling sales of thrombosis brands and facility to Aspen
June 24, 2013Manufacturing and Production, Sales and Marketing Arixtra, GSK, aspen
GlaxoSmithKline says it is considering an offer from South African drugmaker Aspen Pharmacare to take ownership of two thrombosis drugs …
BMS appoints Harman International chief executive
June 24, 2013Manufacturing and Production, Research and Development, Sales and Marketing BMS
Bristol-Myers Squibb has appointed Harman’s chief executive Dinesh Paliwal to its Board of directors.Paliwal will serve as a member of …
Viagra patent expiry opens up market
June 24, 2013Manufacturing and Production, Research and Development, Sales and Marketing ED, Pfizer, generics, viagra
Pfizer lost its UK patent rights to its erectile dysfunction drug Viagra over the weekend, leading to an influx of …
Lundbeck cuts more jobs in Europe
June 24, 2013Manufacturing and Production, Research and Development, Sales and Marketing Lexapro, Lundbeck, cuts
Lundbeck is to cut yet more jobs in Europe as the Danish pharma firm restructures its operations to focus on …
David Haslam: a new chairman for a new NICE
June 24, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Hasmam, NHS, NICE
When NICE was first set up in 1999, technology appraisals of new medicines were its sole focus, but over the …
CQC revelations continue
June 21, 2013Sales and Marketing CQC, NHS, NICE
The turmoil at the Care Quality Commission (CQC) shows no sign of abating as MPs may summon the current leadership …
J&J opens office at Stevenage Bioscience Catalyst
June 21, 2013Manufacturing and Production, Research and Development J&J, JJ, bioscience, catalyst
Johnson & Johnson Innovation has establishment a partnering office at Stevenage Bioscience Catalyst to support emerging entrepreneurs and biotech firms …
Zaltrap ‘no’ from NICE
June 21, 2013Sales and Marketing NICE, Sanofi, Zaltrap
NICE is preparing to discard Sanofi’s Zaltrap as an NHS option for treating metastatic colorectal cancer (mCRC) that is resistant …
UK government keen to reduce drugs bill
June 21, 2013Sales and Marketing NHS, NICE, UK, VBP
The government has shown its hand in the drug pricing debate after asking for a 20% price cut on some …
John Garibotto joins Cellnovo’s Board
June 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cellnovo, Garibotto
UK-based medical device firm Cellnovo has appointed John Garibotto as a non-executive director. Garibotto is a 20-year veteran of the …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
